CA2280729A1 - Coil apparatus and method for delivering diagnostic and therapeutic agents intravascularly - Google Patents

Abstract

This invention is a coil apparatus (170) and method for delivering diagnostic and therapeutic agents intravascularly in which a coil is placed in an artery or other vessel at a diseased location, and the diagnostic or therapeutic agents are delivered by the coil to that specific location. The coil apparatus (170) includes a resilient fiber core (171) enclosed in a soft, hollow polymer tubing (172). The resilient fiber core has a pre-shaped coil at one end that overcomes the susceptibility of the polymer tubing to become uncoiled, while permitting a construction of the coil having a very small diameter. The polymer tubing is a radiopaque, and has a soft surface for engaging the inside of a vessel. The coil is deployed by a deployment device at a specific site in a vessel to be treated. Once at the delivery site, the deployment device ejects the coil out of a delivery sheath into the vessel. The polymer tubing covering the coil can be perforated or porous so that fluid based agents passing through one or more lumens of the tubing are ejected out of the coil to the site to be treated. Alternatively, a soluble coating (173) containing the diagnostic or therapeutic agents can be applied to the outer surface of the polymer tubing, rather than passing fluid based agents through a lumen of the tubing. Variations in the shape of the coil and in the deployment devices are disclosed.

Description

COIL APPARATUS AND METHOD FOR DELIVERING DIAGNOSTIC
AND THERAPEUTIC AGENTS INTRAVASCULARLY
$~~LATED APPLICATIONS
This application is a continuation-in-pan of Applicants' copending U.S.
Application Serial No. 08/801,576, filed on February t4. 1997. which is a continuation-in-part of Applicants' copending LJ.S. Application Serial No.
08/602,424, filed February 1 fi, 1996, now U.S. Patent No. 5,603.694.
BACKGROUND O~ THE INVENTION
Field of the Invention The present invention relates generally to an apparatus and method for delivering diagnostic: and therapeutic agents into a living organism and, in particular, to an infusion coil or coated coil apparatus and method for delivering such therapeutic agents intravascularly.
Descr~i,t~tion of the Related Art Atherosclerosis is a cardiovascular disease in which deposits of plaques (atheromas) containing cholesterol, lipid material, foam cells, lipophages and proliferating smooth muscle cells are within the intima and media of large to small diameter arteries such as the aorta and the iliac, femoral, coronary and cerebral arteries. The resultant stenosis causes reduction in blood flow.
Attempts to treat atherosclerosis have included bypass surgery wherein the diseased vascular segments are augmented by prosthetic or natural grafts. This procedure requires general anesthesia and a substantial healing period after surgery and. thus, is generally limited to cases of severe coronary artery disease.

Other approaches for the recanalization of stenotic vessels include percutaneous transluminal coronary angioplasty (PTCA), atherectomy, stenting and newer modalities of cardiovascular intervention, including laser angioplasty.
The primary drawbacks of these procedures has been the appearance of restenosis at or S near the site of the original stenosis in the blood vessel that requires a secondary angioplasty procedure or a bypass surgery. Another occurrence that reduces the success of a typical angioplasty procedure is that frequently the stenotic plaque or intima of the blood vessel or both are dissected during the angioplasty procedure by the inflation of the balloon. Upon the deflation of the balloon, a section of the dissected lining (commonly termed "flap") will collapse into the bloodstream, thereby closing or significantly reducing the blood flow through the vessel. In these instances, emergency bypass surgery is often required to avoid a myocardial infarct distal to the.
blockage.
In recent years, various devices and methods (other than bypass surgery) for 1 S prevention of restonosis and for repairing damaged blood vessels have become known. These methods typically use an expandable cage or region (commonly termed "stmt") on the distal end of a catheter designed to hold a detached lining against an arterial wall for extended periods to facilitate the reattachment thereof.
Some stems are designed for permanent implantation inside the blood vessel, and others are designed for temporary use inside the vessel.
Typically, the expandable region of the prior art stems is formed by a braided wire or balloon attached to the distal end of the catheter body. Such designs are difficult and expensive to manufacture, and create reliability concerns due to the existence of high stress points located at the connection of the braided wire region with the catheter body and at the connections between the intermingled wire strands.
Alternatively, or in addition to the use of stems, various drugs have been applied to the site of the dilated lesion to prevent or reduce chances of restenosis and to aid in the healing of flaps, dissection or other hemorrhagic conditions that may appear after an angioplasty procedure. The prior art braided wire and balloon stents, as disclosed, for example, in U.S. Patents 4.655,771, 5,295,962, 5,368,566 and WO 98/35717 PC"T/US98102770 -5,421,826, cannot be used to deliver or inject fluid-based agents to the specific site of the lesion while maintaining adequate flow in the vascular lumen. The fluid flow through the lumen is substantially blocked by these stems during use.
In recognition of this problem, temporary stenting catheters with drug delivery capabilities have been developed, as disclosed, for example, in U.S. Patents 5,383,928 and 5,415,637. The '928 patent discloses a coil-shaped stmt covered by a polymer sheath for local drug delivery. A drug is incorporated into the polymer sheath for controlled release of the drug upon insertion. Because the polymer sheath itself is as large as the diameter of the coil, the device cannot be removed from the subject outside of the lab and without a guiding; catheter. Moreover, the device is limited in its ability to adapt to the shape and size of the vessel wall, and in that only drugs that arc compatible with and can be incorporated into the polymer can be delivered by the device.
The temporary stenting catheter of the '637 patent functions to hold a collapsed dissected lining or flap against the blood vessel wall for a sufficient time to allow the natural adhesion of the flap to the blood vessel wall. The stenting catheter of the '637 patent also functions to introduce a drug to the site of the vascular procedure to aid in the adhesion process. and in the prevention of restenosis while allowing the flow of blood through the veasel to locations distal to the catheter.
The catheter assembly of the '637 patent, however, has a number of disadvantages. The catheter assembly is complex and expensive to manufacture.
More importantly, however, the catheter assembly of the '637 is very expensive to use because it requires a guiding catheter to be maintained within the vessel and the patient to be maintained within the catheter lab during use and deployment.
There are other known devices, as disclosed, for example, in U.S. Patent Nos.

4,531,933, 4,694,838, 4,813,925, 4,887, 996, and 5,163,928, that use a catheter having a heat set polymer st:ent at a distal end shaped as a halo or coil. These devices require pushing a rod through the lumen of the heat set curve in the polymer to straighten the device so that it may be inserted into the body through a guide catheter. The rod is then removed and the curve shape of the catheter comes back. These devices suffer from being limited in size due to the fact that a relatively large wire must be used to straighten the device (e.g., 0.014" to 0.016"). Thus, the lumen size of these devices are correspondingly large. The devices also suffer from a lack of ability to be deformed (i.e., coiled, bent, or shaped) without a permanent deformation.
Because of the permanent deformation, the devices fail to track the inside of a vessel that is not round.
The prior art drug delivery systems cannot be left in place for a period of time outside the lab in which the angioplasty was performed, and then removed by a nurse by simply pulling the system out. Any coil that relies on a balloon for its intravascular shape requires inflation to maintain the coil's shape, and the patient is required to stay in the lab under fluoro to make sure the coil stays in place. Any coil that relies on the modules of the polymer to maintain the coi! shape is too rigid to pull out and requires the use of a straightening rod to push through the coil so that the coil straightens out before removal. This procedure would not be permitted outside the catheter lab, thus, adding significant cost to the procedure.
Thus, there is a need for an improved system and method for delivering diagnostic and therapeutic agents intravascularly that overcomes the problems of the existing systems.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a method and system for delivering diagnostic and therapeutic agents intravascularly that overcomes the problems in the above-mentioned prior art.
It is a further object of the present invention to provide a delivery system for delivering diagnostic and therapeutic agents with an e~;tremely soft coil shape for engaging a vessel.
It is a further object of the present invention to provide a delivery system for diagnostic and therapeutic agents that can be removed from the body without the use of guiding catheters or introduction devices, and that can be left in place for a period of time outside the lab where it was installed and removed by simply pulling it out.

-S-It is a further object of the present invention to provide a delivery system for diagnostic and therapeutic agents that is very small and flexible, and that has an improved ability to track the inside of a vessel and to be deformed (i.e., coiled, bent, or shaped) without permanent deformation.
It is a further object of the present invention to provide a coil-shaped delivery system with the above advantages that has a radiopaque polymer tubing or radiopaquc coating over a polymer tubing for observation under a fluoroscope or other X-ray device.
It is a further object of the present invention to provide a coil-shaped delivery system having multiple lumens for delivering fluid-based agents and/or withdrawing fluid samples.
It is a further object of the present invention to provide a coil-shaped delivery system having a number of different shapes to suit a particular application.
It is a further object of the present invention to provide a coil-shaped delivery system having an inner sheath to guide diagnostic and therapeutic agents to a wall of a vessel.
It is yet a further object of the present invention to provide a coil-shaped delivery system having a soluble coating on the surface of a coil that dissolves when placed in a body fluid in a vessel.
Additional objects, advantages, and novel features of the invention will be set forth in the following description, and will become apparent to those skilled in the art upon reading this description or practicing the invention. The objects and advantages of the invention may be realized and attained by the appended claims.
To achieve the foregc»ng and other objects and in accordance with the purpose of the present invention, as embodied and broadly described herein. the coil apparatus of the present invention comprises a resilient fiber core having a linear portion and a coiled portion, and a polymer tubing encasing the resilient fiber core and adapting to the shape of the resilient fiber core, the polymer tubing comprising a first portion encasing the linear portion of the resilient fiber core and a second portion encasing the coiled portion of the resilient fiber core.

In one embodiment, the polymer tubing has a lumen extending along a length of the polymer tubing, and the second portion of the polymer tubing comprises means for releasing a fluid-based agent delivered through the lumen from the coil apparatus.
The releasing means may comprises a series of openings spaced along the second portion of the polymer tubing, or a porous, braided, or stitched material of the polymer tubing.
The polymer tubing may comprise multiple lumens for delivering fluid-based agents and/or withdrawing fluid samples. Moreover, an inner sheath may be secured to the polymer tubing to guide fluid-based agents to a wall of a vessel in which the coil is deployed.
In an alternative arrangement, an outer surface of the coiled portion of the polymer tubing is covered with a soluble coating containing a therapeutic agent. 'fhe soluble coating is then dissolved when the coil is placed in a body fluid contained in a vessel. In another arrangement, a first portion of the polymer tubing is covered with a soluble coating containing a therapeutic agent, and a second portion of the polymer tubing has a releasing means for delivering fluid-based agents from a lumen of the polymer tubing.
With the construction of the present invention, the coil apparatus can be extremely small. For example, the resilient fiber core can be formed of a metallic steel heat-tempered spring alloy, such as a titanium-nickel-chromium alloy, or a boron fiber having a diameter of 0.001 to 0.006 inches. The polymer tubing can have an outside diameter of 0.003 to 0.014 inches and an inside diameter of 0.002 to 0.008 inches. The polymer tubing is preferably formed of a very soft material, such as nylon, urethane, PE and TFE polymer materials, and has a Shore D hardness of approximately 40 so as to minimize resistance to the coiled portion of the resilient fiber core and prevent damage to a vessel during use. The polymer tubing is constructed of a polymer compounded with a radio opacifier at a loading high enough to make the polymer radiopaque.
In a first embodiment, the coiled portion of the resilient fiber core is shaped into a forward feed coil shape extending away from the linear portion of the resilient _ '7 _ fiber core.
In a second embodiment, the resilient fiber core is shaped into a reverse feed coil shape with a bent transition portion between the linear portion and the coiled portion, the bent transition portion directing the coiled portion in a reverse direction back along the linear portion.
In additional embodiments, the coiled portion of the resilient fiber core is shaped into a forward feed coil shape extending away fW m the linear portion of the resilient fiber core and includes a distal end portion that can be engaged by a catheter for deployment purposes.
The resilient inber core may also be pre-shaped in a numher of different shapes to suit a particular application. For example, the resilient (iher core may be spiral-shaped in plan view, or helical-shaped with a tapered diameter.
In a further aspect of the present invention, in accordance with its objects and purposes, the present invention comprises a combination of a coil apparatus for delivering diagnostic and therapeutic agents intravascularly and an apparatus for deploying the coil apparatus at a desired location in a vessel, the coil apparatus comprising a resilient fiber core having a linear portion and a coiled portion, and a polymer tubing encasing the resilient fiber core and adapting to the shape of the resilient fiber core, the polymer tubing comprising a first portion encasing the linear portion of the resilient fiber core and a second portion encasing the coiled portion of the resilient fiber core.
The apparatus for deploying the coil apparatus comprises a delivery sheath, the delivery sheath having an inside diameter that is smaller than a preset diameter of the coiled portion for compressing the coil apparatus during deployment.
In one embodiment, the apparatus for deploying the coil apparatus further comprises a push tube for pushing the coil apparatus out of the delivery sheath during deployment, the push tube being slidable over a linear portion of the coil apparatus.
In another embodiment, the apparatus for deploying the coil apparatus further comprises a deployment catheter that is slidable over the coil apparatus, the deployment catheter comprising a slotted distal end for receiving the bent transition _g_ portion of the coil apparatus to permit pushing and twisting of the coil apparatus during deployment.
In other embodiments, the apparatus for deploying the coil apparatus further comprises a deployment catheter having a means for holding the distal end portion to permit pushing and twisting of the coil apparatus during deployment. The holding means may comprise a notch and snare or other suitable holding structure across a distal end of the deployment catheter for receiving and holding the distal end portion of the infusion coil apparatus. Alternatively, the holding means may utilize a friction lock formed in the distal end of the deployment catheter into which the distal end portion of the infusion coil apparatus can be inserted and securely held during deployment.
In another embodiment, a first marker is provided at a forward distal end of the deployment catheter and a second marker is spaced axially rearwardly from the first marker. The first and second markers are radiopaquc for determining placement of the infusion coil apparatus within a vessel. The first and second markers are spaced apart a distance equal to an axial length of the coiled portion in a relaxed position of the coiled portion.
According to another embodiment of the present invention. the deployment apparatus is further provided with a proximal holding tube positioned over a linear portion of the infusion coil. The proximal holding tube has a distal end abutting a coiled portion of the infusion coil and is secured to the infusion coil. The proximal holding tube permits manipulation of the infusion coil during deployment using the proximal holding tube in conjunction with the deployment catheter.
In another embodiment of the present invention, the delivery sheath of the deployment apparatus further comprises a guide tube extending from a point adjacent a distal end of the delivery sheath to an opening in a side wall of the delivery sheath.
The guide tube is secured to the side wall of the delivery sheath and has an inner diameter large enough to permit a guide wire to pass therethrough.
In a further aspect of the present invention, in accordance with its objects and purposes. the present invention comprises a method for delivering diagnostic and therapeutic agents into a vessel, comprising the steps of providing an infusion coil apparatus having a resilient fiber core encased by a soft polymer tubing.
loading the infusion coil apparatus into a delivery sheath, the delivery sheath having an internal diameter which is smaller than a preset diameter of a coiled portion of the resilient fiber core, inserting the delivery sheath and the infusion coil apparatus into a vessel, and pushing the infusion coil apparatus out of the delivery sheath whereby the resilient fiber core causes the infusion coil apparatus to increase in diameter and lodge in the vessel. The method further comprises the step of feeding a fluid-based agent through the polymer tubing of the infusion coil apparatus into the vessel, or the step of covering an outer surface of the coiled portion of the polymer tubing with a soluble coating containing a therapeutic agent.
In one embodiment of the present invention, the method further comprises the steps of sliding a push tube over a linear portion of the infusion coil apparatus, pushing the infusion coil apparatus out of the delivery sheath using the push tube, and removing the push tube and the delivery sheath from the vessel while maintaining the infusion coil apparatus within the vessel.
In another embodiment of the present invention. the method further comprises the steps of providing the infusion coil apparatus with a reverse feed coil shape with a bent transition portion between a linear portion and a coiled portion, the bent transition portion directing the coiled portion in a reverse direction back along the linear portion, providing a deployment catheter having a slotted distal end, sliding the deployment catheter over the infusion coil apparatus and receiving the bent transition portion of the infusion coil apparatus in the slotted distal end of the deployment catheter.
In other embodiments of the present invention, the method further comprises the steps of providing the infusion coil apparatus with a forward feed coil shape extending away from a linear portion of the resilient fiber core, and a distal end portion, providing a deployment catheter having a holding structure in a distal end of the deployment catheter, and receiving and securing the distal end portion of the infusion coil apparatus in the holding structure of the deployment catheter.

WO 98/35717 PCT/US98/02770 _ The method may further comprise the steps of pushing the infusion coil apparatus out of the delivery sheath into the vessel with the deployment catheter, and twisting the deployment catheter to rewind the infusion coil apparatus into a deployed position against a wall of the vessel. The method also may include the steps of providing first and second radiopaque marks on the deployment catheter, the first and second marks being spaced apart a distance approximately equal to an axial length of the coiled portion in a relaxed position of the infusion coil apparatus, and twisting the deployment catheter to rewind the infusion coil apparatus until the axial length of the coiled portion is approximately the same as the distance bcnvccn the first and second marks.
In another embodiment of the present invention. the method for delivering diagnostic and therapeutic agents further comprises the steps of providing the infusion coil apparatus with a forward feed coil shape extending away from a linear portion of the resilient fiber core, providing a proximal holding tube over a linear portion of the infusion coil, the proximal holding tube having a distal end abutting a coiled portion of the infusion coil, the proximal holding tube being secured to the infusion coil, sliding the proximal holding tube and the deployment catheter in opposite directions to elongate and reduce the diameter of a coiled portion of the infusion coil apparatus, placing the elongated coil into the delivery sheath, pushing the infusion coil apparatus out of the delivery sheath into the vessel using the deployment catheter and the proximal holding tube, and sliding the proximal holding tube and the deployment catheter in opposite directions to compress and increase the diameter of the coiled portion of the infusion coil apparatus, whereby the infusion coil apparatus is placed in a deployed position against a wall of the vessel.
In another embodiment of the present invention, the method further comprises the steps of providing a guide tube within the delivery sheath, the guide tube having a first distal end adjacent to a distal end of the delivery sheath, and a second proximal end in communication with an opening through a side wall of the delivery sheath, and sliding the guide tube over a guide wire to facilitate the step of inserting the delivery sheath and the infusion coil apparatus into a vessel.

wo 9sr~s~m Qc~r~s9sio2~~o -RRIFF DESCRIPTION OF THE DRAWINGS
The present iinvention will become more clearly appreciated as the disclosure of the present invention is made with reference to the accompanying drawings.
In the drawings:
Fig. 1 is a perspective view of an infusion coil assembly according to a first embodiment of the present invention.
Fig. 2 is an exploded perspective view of the components shown in Fig. 1.
Figs. 3A to :1C illustrate the steps and mechanism for deploying the infusion coil of the first embodiment. Fig. 3A shows the infusion coil in a loaded position.
Fig. 3B shows the infusion coil in a deployed position within an artery wall.
Fig. 3C
shows the removal of the deployment mechanism.
Fig. 4 is a perspective view of a resilient fiber in an alternate coil shape according to a second embodiment of the present invention.
Fig. 5 is a perspective view of an infusion coil assembly according to the second embodiment.
Figs. 6 to 8 illustrate the steps and mechanism for deploying the infusion coil of the second embodiment. Fig. 6 shows the infusion coil in a relaxed position on a deployment catheter. Fig. 7 shows the infusion coil in a stretched position on the deployment catheter during insertion into a guide catheter. Fig. 8 shows the torquing of the deployment catheter to rewind the infusion coil.
Fig. 9 is a perspective view of the infusion catheter deployed in an artery having a round cross-section.
Fig. 10 is a perspective view of the infusion catheter deployed in an artery having an oval or oblong cross-section.
Fig. 11 is a perspective view of an infusion coil. according to a third embodiment of the present invention, in a relaxed position on a deployment catheter.
Fig. 12A is a perspective view of an infusion coil held by a friction lock of a deployment catheter according to a fourth embodiment of the present invention.
Fig. 12B is a perspective view of the deployment catheter shown in Fig. 12A

WO 98/35717 PC"T/US98/02770 -with a modified friction lock.
Figs. 13A to 13C illustrate an infusion coil and deployment apparatus according to a fifth embodiment of the present invention. Fig. 13A shows the infusion coil in a shortened. radially enlarged position. Fig. 13B shows the infusion coil in an elongated, radially reduced position. Fig. 13C shows a perspective view of the infusion coil and deployment apparatus.
Fig. 14 is a perspective view of a sixth embodiment of the present invention for deploying the infusion coil assembly over a guide wire.
Fig. 1 S is an exploded perspective view of an infusion coil showing an alternate construction of the polymer tubing according to the present invention.
Fig. 16 is an assembled perspective view of the infusion coil shown in Fig.
15.
Figs. 17A to 17C show a series of steps for sealing the distal end of the infusion coil by knotting and thermally consolidating the end of the infusion coil.
Fig. 18 is an enlarged perspective view of the infusion coil showing a plurality I 5 of circumferentially spaced rows of openings for permitting delivery of diagnostic and therapeutic agents through the polymer tubing.
Fig. 19 is a cross-sectional view of a first multiple lumen infusion coil apparatus according to the present invention.
Fig. 20 is a cross-sectional view of a second multiple lumen infusion coil apparatus according to the present invention.
Fig. 21 is a cross-sectional view of a third multiple lumen infusion coil apparatus according to the present invention.
Fig. 22 shows an infusion coil apparatus according to the present invention having a spiral shape in plan view.
Fig. 23 shows an infusion coil apparatus according to the present invention having a helical shape tapering from a large proximal end to a small distal end.
Fig. 24 shows an infusion coil apparatus according to the present invention having a helical shape tapering from a small proximal end to a large distal end.
Fig. 25 is a perspective view of an infusion coil apparatus according to the present invention having an inner sheath affixed to a coiled portion of the apparatus.

WO 98/35717 PCT/US98/02770 - , Fig. 26 is a cross-sectional view of the infusion coil apparatus shown in Fig.
25, in a deployed position within a vessel.
Fig. 27 is a perspective view of a coil apparatus according to another embodiment of the present invention, wherein an outer surface of the polymer tubing is covered with a soluble coating.
Fig. 28 is an enlarged sectional view of a coated segment of the coil apparatus shown in Fig. 27.
Fig. 29 is a perspective view of a coil apparatus according to another embodiment of the present invention, wherein a first portion of the polymer tubing is covered with a soluble coating, and a second portion of the polymer tubing has openings for delivering fluid-based agents from a lumen thereof.
DETAILED DESCRIPTION OF THE PREFERRFD EMBODIMENTS
A first embodiment of the present invention will be described in detail hereinafter with reference to Figs. 1, 2, and 3A to 3C.
Referring to Fig. 1, an infusion coil 10 according to the first embodiment is shown in a loaded configuration (i.e., prior to deployment) in a delivery sheath 11 for deployment into a vessel of a subject. The infusion coil 10 includes a pre-shaped resilient fiber core 1.2, as seen in the exploded view of Fig. 2. The resilient fiber core 12 has a first linear portion 13 and a second coiled portion 14. The coiled portion 14 is formed at an end of the device for insertion into a vessel. The resilient fiber core 12 is encased by a soft, radiopaque polymer tubing 15 that adapts to the shape of the resilient fiber core 12, including the coiled portion 14. The resilient fiber core 12 extends through the lumen of the soft polymer tubing 15.
The preshape of the coiled portion 14 of the resilient fiber core 12 is a coil configuration with an outer diameter of the coil chosen so that it is slightly larger than the vessel in which the infusion coil 10 will be deployed. The combination of the resilient fiber core 12 and the soft polymer tubing 15 permit the infusion coil 10 to be wound into a much tighter coil than coils for delivering diagnostic and therapeutic agents of the prior art.

wo 98r~s~m rc~rius98ioi~~o -The soft polymer tubing 15 includes a series of holes 16 therein spaced along the circumference of the coil shape. The holes 16 provide an outlet for fluid-based agents injected through the tubing 15. The holes 16 in the tubing 15 rnay be formed by drilling, lasing, machining, punching, and so forth. Slots can be used in the coil of the tubing I 5 instead of holes. In addition, the coiled portion of the tubing 15 can be constructed of porous materials such as PTFE and PVDF, or the end of the tubing can be braided, stitched, and so forth.
In operation, the infusion coil 10 in its loaded position (Figs. 1 and 3A) is inserted into the body and directed to the desired site through an appropriate guiding catheter and/or guide wire. The device can be inserted directly over a guide wire already in place, as further explained below. The axial length of the device is minimized because the infusion coil 10 is in compression during deployment.
After reaching the desired location (Fig. 38), a push tube 17 is used to push the infusion coil I 0 out of the delivery sheath 1 1. As the infusion coil 10 exits the sheath 1 I, the resilient fiber core 12 springs back to its pre-set condition and lodges the infusion coil I 0 in a vessel 18. The push tube 17 is fed directly over the linear portion of the infusion coil to provide positive attachment to the coil 10 for pushing and to prevent accidental over-extension of the push tube 17 into the vessel 18. After the infusion coil 10 is pushed completely out of the delivery sheath 11, the push tube 17 and delivery sheath 11 can be removed (Fig. 3C) leaving the infusion coil 10 in the vessel 18 by itself.
The polymer tubing 15 over the resilient fiber core 12 serves to cushion the impact of the infusion coil 10 onto the wall of the vessel 18 and provides a path for infusion of diagnostic and therapeutic diagnostic and therapeutic agents. The holes 16 placed around the entire periphery of the polymer tube 15 in the coil section permit antithrombotic fluid-based agents to be introduced over the entire circumference of the infusion coil 10 to prevent blood clotting problems associated with the deployment of similar devices.
The following dimensions and specific materials of the components of the delivery system are given by way of example only. The delivery sheath 11 can be formed of polymer (nylon) or fluorpolymer tube (teflon) having an outside diameter of 0.066" and an inside diameter of 0.058". The push tube 17 can be formed of a polymer tube (nylon) with or without a wire reinforcement. The push tube 17 can have an outside diameter of 0.032" and an inside diameter of 0.018".
The resilient fiber core 12 of the infusion coil 10 can be formed of a metallic steel heat-tempered spring alloy, such as a titanium-nickel-chromium alloy, a boron fiber, or other suitable resilient material. The resilient fiber core preferably has a diameter of 0.002" to 0.006". The polymer tubing 1 S can be formed of a nylon, urethane, PE or TF>=? polymer material having an outside diameter of 0.012" to 0.014"
and an inside diameter of 0.006" to 0.008". The polymer tubing 15 of the coil 10 is preferably very soft so that it offers virtually no resistance to the coiled portion 14 of the preformed resilient fiber core 12. This allows the resilient fiber core 12 to have a diameter as small as 0.002" and still maintain enough springback in the coil assembly to be lodged within a vessel 18. This is a crucial aspect of the device in that it is soft enough to prevent damage to the walls of the vessel 18 as it is inserted and removed.
Referring to Figs. 4 t.o 8, a second embodiment of the present invention will be described. In the second embodiment, an infusion coil 20 is formed using a resilient fiber core 21 that is preshaped into a reverse feed coil shape, as shown in Fig. 4.
Specifically, a bent transition portion 22 between a linear portion 23 of the resilient fiber core 21 and a coiled portion 24 of the resilient fiber core 21 directs the coiled portion 24 in a reverse direction back along the linear portion 23, rather than forward away from the line~~r portion, as in the embodiment of Fig. 1.
A polymer tubing 25 is then slid over the resilient fiber core 21, as in the first embodiment, and the infusion coil 20 takes the shape of the resilient fiber core 21, as shown in Fig. 5.
Referring to Figs. 6 to 8, the steps and mechanism for deploying the infusion coil 20 of the second embodiment will be described. Fig. 6 shows the infusion coil 20 in a relaxed position on a deployment catheter 26. The deployment catheter 26 is slid over a linear portion 27 of the infusion tube 20. The deployment catheter 26 includes a slotted distal end 28 for receiving a portion of the infusion coil 20 at or near the WO 98/35717 PC'T/US98/02770 -transition portion 29 to permit pushing and twisting of the infusion coil 20 during deployment.
As shown in Fig. 7, the infusion coil 20 is pushed through a standard introduction device 30 for deployment, such as a guide catheter (i.e., delivery sheath) or a guide wire. The infusion coil 20 elongates into a stretched position when inserted into these devices because the coil 20 has a much larger relaxed diameter (e.g., 2.5 mm to 6 mm) than the passage diameter of the guide catheter or other delivery devices 30 (e.g., I .5 mm to 2.5 mm). Once at the desired deployment location, the deployment catheter 26 is pushed and twisted to force the infusion coil 20 out of the guide catheter 30 and to rewind into the coil's original configuration, as shown in Fig.
8. Since the polymer tubing 15 is radiopaque, the infusion coil 20 can be easily observed during deployment on a fluoroscope or other suitable X-ray device.
The deployment catheter includes a first marker 31 at a forward distal end and a second marker 32 spaced axially rearwardly from the first marker 31. The first and I S second markers 31 and 32 are radiopaque and are spaced apart a distance approximately equal to the axial length of the coil 20 in its relaxed position (Fig. 6).
The markers 31 and 32 are used to determine coil placement within a vessel.
Because the markers 31 and 32 are radiopaque. they can be observed using a fluoroscope or other suitable X-ray device.
Once the markers 31 and 32 ai~e observed at the desired deployment site, the deployment catheter 26 is twisted and pushed fiom the guide catheter 30, as described above. The deployment catheter 26 is preferably twisted until the coil portion of the infusion coil 20 assumes an axial length approximately equal to the axial length in its relaxed position.
The deployment procedure described above for the second embodiment allows for simple positive deployment of the infusion coil 20. More importantly, the deployment procedure allows for positioning of the device in an irregularly shaped vessel while maintaining a coil configuration that is in contact with the vessel wall along its entire periphery. To illustrate this point, Fig. 9 shows the infusion coil 20 of the second embodiment deployed in an artery 33 having a round cross-section, which is an ideal deployment site for most stems and delivery devices. On the other hand, Fig. 10 shows the infusion coil 20 of the second embodiment deployed in an artery 34 having an oblong or other irregularly shaped cross-section. In both instances, the infusion coil 20 of the present invention is soft enough to conform to any differences and irregularities in the vessel wall. Moreover, the twisting motion ensures that the infusion coil 20 is placed against the vessel wall. A stiffer tube, such as one that relies on polymer resiliency to form a coil, rather than a resilient fiber core as in the present invention, will bridge such irregularities.
Referring to Fig. 1 l, a third embodiment of the present invention will be described. In the third embodiment, an infusion coil 40 with a distal end portion 41 is formed using a resilient fiber core that is preshaped into a forward-feed coil shape. as shown in Fig. I I . /~ deployment catheter 42 is provided for deploying the infusion coil 40 in a manner similar to that described above for the second embodiment.
The deployment catheter 42 includes a notch 43 and a snare device 44 for holding the distal end portion 41 of the infusion coil 40.
With the deployment catheter 42, the distal end of the infusion coil 40 is grabbed in the snare device 44 or similar clamp at the end of the deployment catheter 42. This allows the coil 40 to be dragged into place and twisted. similar to the procedure described above for deploying the infusion coil 20 of the second embodiment. First and second markers 45 and 46 are provided to determine coil placement within a vessel, similar to the markers 3 I and 32 of the second embodiment.
Figs. 12A and 12B illustrate an infusion coil apparatus according to a fourth embodiment of the present invention. As shown in Fig. 12A, the infusion coil apparatus includes an infusion coil 50 having a resilient fiber core that is preshaped into a forward-feed coil shape, as in the first and third embodiments. A
deployment catheter 51 is provided for deploying the infusion coil 50 in a manner similar to that described above for the third embodiment.
The deployment catheter 51 includes a friction lock 52 formed in a distal end thereof for receiving and holding a distal end 53 of the infusion coil 50. The friction _18_ lock 52 comprises an axially extending bore at the end of the deployment catheter S 1 into which the distal end 53 of the infusion coil 50 is inserted. The resilient nature of the infusion coil 50 created by the resilient fiber core creates a friction holding force between the infusion coil 50 and the axially extending bore upon insertion of the distal end 53 of the infusion coil 50 into the axially extending bore.
A push rod 54 is inserted into the deployment catheter 51 to release the friction lock 52 between the infusion coil 50 and the deployment catheter 51 after the infusion coil 50 is positioned in a vessel at a desired location. To release the friction lock 52, the push rod 54 engages and pushes the distal end 53 of the infusion coil 50 out of the axial bore of the deployment catheter 51.
As with the second and third embodiments described above. the deployment catheter 51 of the fourth embodiment, in operation, drags the infusion coil 50 into place and deploys the infusion coil 50 into a desired deployment location. The deployment catheter 51 can also be provided with radiopaquc markers (not shown) to facilitate observation on a fluoroscope or other suitable X-ray device.
Fig. 12B is a perspective view of a deployment catheter 51' with a modified friction lock 52'. The modified friction lock includes a notch SS in a side wall of the distal end of the deployment catheter 51'. In use, the infusion coil 50 is inserted into the axial bore of the deployment catheter 51' and positioned such that a distal end portion of the infusion coil 50 is received in the notch 55. The notch 55 facilitates twisting of the infusion coil 50 during deployment to rewind the infusion coil 50 into its original configuration.
Referring to Figs. 13A to 13C, an infusion coil and deployment apparatus according to a fifth embodiment of the present invention will be described.
The infusion coil 60 and deployment catheter 61 used in the fifth embodiment are essentially the same as the infusion coil 50 and deployment catheter 51 used in the fourth embodiment. Specifically,, the deployment catheter or distal coil holding tube 61 includes a friction lock 62 in the form of an axial bore for securing a distal end 63 of the infusion coil 60 during deployment. A push rod 64 is provided within the distal coil holding tube 61 to release the friction lock 62. In addition, the deployment WO 98/35717 t'CT/US98/02770 -apparatus includes a proximal holding tube 65 positioned over a linear portion 66 of the infusion coil 60. A containment sheath 67 is disposed over both the proximal and distal holding tubes.
The assembly shown in Figs. 13A to 13C is particularly useful in instances S when a physician desires the ability to position and adjust (compress, elongate, etc.) the infusion coil 60. This is done by first grabbing thr distal end 63 of the infusion coil 60 with the friction lock 62, as previously described. and also grabbing the proximal, linear portion 66 of the infusion coil 60 using thr proximal holding tube 65.
The proximal holding tube 65 is slid over the infusion coil fi(1 into a position abutting the coiled portion of the infusion coil 60. The proximal holding; tube 65 iv then clamped or otherwise secured to the infusion coil 60 at the proximal end of the infusion coil 60 outside the containment sheath 67 (at the hub of the deployment apparatus).
In a pre-deployed state of the infusion coil assembly (Fig. l3Fi), the proximal holding tube 65 and the distal holding tube 61 are slid in opposite directions to elongate the coil 60 and are then pulled into the sheath 67. To deploy the device, the distal holding tube til is pushed out of the sheath 67 followed by the proximal holding tube 65 (Fig. 13A). The distal and proximal holding tubes 61, 65 can then be manipulated by the physician to compress and elongate the infusion coil 60 as desired.
Referring to Fig. 14, a sixth embodiment having a modified deployment assembly for deploying an infusion coil over a guide wire will be described.
Guide wires for guiding catheters and deployment devices into a desired location in a vessel of a patient are well known.
As shown in Fig. 14, a modified delivery sheath 70 and push tube 71 are provided for deploying the infusion coil 72 over an existing guide wire (not shown).
A guide tube 73 extends from a front opening 74 of the delivery sheath 70 to an opening 75 in a sidf: wall of the delivery sheath 70. The guide tube 73 is permanently secured to the side wall of the delivery sheath 70 by a suitable adhesive or thermal bonding process. T'he guide tube 73 has an inner diameter large enough to permit the guide wire to pass freely therethrough.

The infusion coil 72 is loaded in the delivery sheath 70 by inserting the linear portion 76 of the infusion coil and push tube 7I into the delivery sheath 70 through the front opening 74. In its loaded position, the coiled portion of the infusion coil 72 is positioned coaxially about the front portion of the guide tube 73. In this manner, the infusion coil 72 can be easily pushed out of the delivery sheath 70 during deployment.
In operation, a proximal end of a guide wire extending outside of a patient is inserted into the front end 77 of the guide tube 73 and pushed through the guide tube 73 until the guide wire exits through the opening 75 in the side wall of the delivery sheath 70. The proximal end of the guide wire is then held by the physician while the loaded delivery sheath 70 and infusion coil assembly are pushed into the vessel of the patient to the desired location using the guide wire for guidance.
The guide tube 73 and modified delivery sheath 70 permit deployment of the infusion coil assembly over an existing guide wire without removing the guide wire and without requiring a guide wire extension to be attached to the guide wire.
With the present arrangement, only a short portion of the guide wire must be exposed outside of the patient to permit the delivery sheath 70 to be introduced over the guide wire and into the patient.
By way of example, a 0.016 to 0.018 inch diameter guide wire may be used for a 0.14 inch internal vessel diameter. The guide tube 73 in this example preferably has a 0.020 inch internal diameter (0.022 inch external diameter), and the delivery sheath preferably has a 0.058 inch internal diameter (0.065 inch external diameter).
Referring to Figs. 15 and 16, an alternate construction of an infusion coil 80 according to the present invention will be described. This alternate construction can be used for any of the coil shapes of the first three embodiments described above, as well as other similar devices.
The polymer tubing 81 of the coil 80 is formed from a braided, stitched or porous tube, such as nylon braids, PVDF porous tubing, or PTFE porous tubing.
For a typical catheter construction, the tubing 81 (preform) is cut to approximately 4' to 5' long. The first 95% of the braid./stitch/porous tubing 81 is consolidated by placing the tubing (preform) on a mandrel and heat consolidating the tubing (preform) with a heat shrink, or coating/impregnating the tubing (preform) with a urethane or similar material.
The result of this process, as shown in Fig. 15, is a polymer tubing 81 with a porous or braided end portion 82 and a consolidated (i.e., non-porous) main portion 83. The polymer tubing 81 is then placed over a resilient fiber core 84, as in the previous embodiments. The final result, as shown in Fig. 16, is a soft infusion coil 80 having a porous polymer coating 82 for delivering fluid-based agents about the circumference of the coil.
The soft polymer tubing 81 of the present invention is preferably constructed of a polymer compounded with a radio opacifier at a loading high enough to make it radiopaque. For example, the polymer can be compounded with approximately 75%
by weight tungsten. The soft polymer tubing 81 can also be made radiopaque using a suitable coating containing a radio opacifier applied over the polymer tubing.
The distal end of the infusion coil in each of the disclosed embodiments can be sealed or closed in a number of ways according to the present invention. In some applications, particularly where the coiled portion of the polymer tubing is highly porous, it may be unnecessary to close the distal end of the infusion coil.
However, in other applications, particularly where a limited number of openings are provided for delivery of fluid-based agents through the polymer tubing, it may be important to close or seal the distal end to prevent the fluid=based agents from flowing out the end of the infusion coil instead of through the delivery openings.
A first way of sealing the distal end of the infusion coil is to knot and consolidate the end of the infusion coil, as shown in Figs. 17A to 17C. As shown in Fig. 17A, a knot 90 is formed in the end of the infusion coil with both the polymer tubing 91 and the resilient fiber core 92. The knot 90 is then pulled tight, as shown in Fig. 17B, and the excess polymer tubing 91 and resilient fiber core 92 extending past the knot 90 are cut off. The knot 90 is then preferably covered by a short length (e.g., 1-2 mm) of heat shrink tubing 93 (e.g., plastic), as shown in Fig. 17C. The heat shrink tubing 93 is heated and shrunk so that the heat shrink tubing 93 flows over the cut end 94 of the infusion coil and permanently consolidates the knot 90 and heat shrink tubing 93 at the distal end of the infusion coil. As a result, the resilient fiber core 92 is permanently anchored within the polymer tubing 91, and the distal end of the infusion coil is sealed to prevent fluid-based agents from flowing therefrom.
A second way to seal the distal end of the infusion coil is to dip the end of the polymer tubing in a potting agent, such as medical grade silicon, cyanoacrylate, or other suitable adhesive. The potting agent moves into the polymer tubing by capillary action and then cures to form an effective seal and anchor for the resilient fiber core in the end of the infusion coil.
A third way to seal the distal end of the infusicm coil is to merely stretch the polymer tubing past the end of the resilient fiber core. l )pon stretching a sufficient length, the polymer tubing necks down and permanently sets in such a way as to close the end of the polymer tubing against the flow of fluid-based agents therethrough.
The result is a feathered, closed portion of the polymer tubing that extends slightly past the end of the resilient fiber core:
As explained above, holes 16 may be formed in the polymer tubing of the infusion coil by drilling, lasing, machining, punching, and so forth. The holes 16 are preferably formed in the polymer tubing in a plurality of circumferentially spaced rows extending along the length of the coiled portion of the polymer tubing 15. For example, as shown in Fig. 18, three rows of holes 16 can be formed in the polymer tubing 15 with each row of holes 16 being spaced 120 degrees apart from the other rows. The circumferentially spaced rows of holes 16 provide two significant advantages. First, the multiple rows of holes 16 ensure that fluid-based agents will flow about an upstream surface of the coiled portion'of the polymer tubing 15 to prevent blood clotting at the point where the blood initially contacts the polymer tubing 15. Second, the multiple rows of holes 16 provide manufacturing convenience in that it is unnecessary to take into account the circumferential location of the holes 16 when forming the coiled portion of the infusion coil.
As shown in Figs. 19 to 21, multiple Lumen infusion coils incorporating the features of the present invention can be formed for delivering fluid-based agents and/or withdrawing fluid samples. The particular shape of the multiple lumen infusion coils shown in Figs. 19 to 21 can be any of the coil shapes described in this application and shown in the other drawings. Similarly, the particular deployment method used for the multiple lumen infusion coils can be any of the methods described herein and shown in the drawings.
The multiple lumen infusion coil 100 shown in Fig. 19 includes a resilient fiber core 1 OI having a first linear portion and a second portion (not shown) which is preshaped into a coiled shape as in the previously described embodiments. A
polymer tubing assembly in 'this embodiment includes a first polymer tubing 102 secured to a second polymer tubing 103 in a side-by-side manner, each polymer tubing having a lumen extending along a length thereof. The first polymer tubing 102 is slid over the resilient fiber core 101, and the infusion coil 100, including both the first and second polymer tubings 102, 103, takes the shape of the resilient fiber core 101.
Thus, a multiple lumen inftlsion coil 100 is provided, which is capable of separately delivering 1 S fluid-based agents i:hrough the respective lumens of the first and second polymer tubings 102, 103 and/or withdrawing fluid samples.
As shown in Fig. 20, a multiple lumen infusion coil 110 can also be provided having first, second and third polymer tubings 112, 113, 114 secured together with three distinct lumens for separately delivering fluid-based agents and/or withdrawing fluid samples. As in the embodiment shown in Fig. 19, a single resilient fiber core 111 extends through the lumen of one of the polymer tubings 112, which is sufficient to cause all of the polymer tubings 112, 113, 114 to adapt to the coiled shape of the resilient fiber core 111.
As shown in Fig. 21, a multiple lumen infusion coil 120 according to the present invention c;an also be made by forming multiple lumens 121, 122 through a one-piece polymer member. A resilient fiber core 123 extends through one of the lumens 121 to cause the infusion coil 120 to adapt to a coiled shape of the resilient fiber core 123. In each of the multiple lumen embodiments shown in Figs. 19 to 21, the polymer tubing must be made from a very soft and flexible polymer material to permit the polymer tubing to adapt to the shape of the resilient fiber core when the infusion coil is deployed.
Referring to Figs. 22 to 24, additional embodiments of the present invention will be described. Specifically, Fig. 22 shows an infusion coil 130 having a spiral shape in plan view, Fig. 23 shows an infusion coil 140 having a helical shape tapering S from a large proximal end 141 to a small distal end 142, and Fig. 24 shows an infusion coil 150 having a helical shape tapering from a small proximal end 151 to a large distal end 152.
In each of the embodiments shown in Figs. 22 to 24, an infusion coil is formed using a resilient fiber core which is preshaped into the particular shape shown in the drawings. A soft polymer tubing is then slid over the resilient fiber core, as in the embodiments described above, and the infusion coil. including the polymer tubing, takes the shape of the resilient fiber core. As in the other embodiments of the present invention described above, the polymer tubing has a lumen extending over its length and openings, pores, braids, or the like for releasing fluid-based agents delivered I S through the lumen into a vessel.
The shape of the infusion coil can be selected to adapt the infusion coil to a particular use or position within a patient's vessel. For example, the spiral-shaped infusion coil 130 shown in Fig. 22 may be particularly useful in a relatively wide, flat vessel or body cavity, while the helical-shaped infusion coils 140, 150 shown in Figs.
23 and 24 may be particularly useful in tapered vessels.
Referring to Figs. 25 and 26, an infusion coil 160 having an inner sheath 161 affixed to a coiled portion 162 of the infusion coil will be described. The infusion coil 160 shown in Figs. 25 and 26 is essentially the same as the infusion coil 10 shown in Figs. 1 to 3. except that the inner sheath 161 is affixed to an inner diameter of the coiled portion of the polymer tubing 163.
The inner sheath 161 is preferably a soft flexible tubing that takes the shape of the coiled portion 162 of the infusion coil I 60. When the infusion coil I 60 is deployed in a vessel 164 (Fig. 26), the inner diameter of the inner sheath 161 defines a passage 165 that permits body fluids to continue flowing through the vessel I
64. The outer diameter of the inner sheath 161 and the coils 166 of the infusion coil 160 define pockets 167 along the length of the inner sheath 161. The pockets 167 function to trap fluid-based agents delivered by the infusion coil 160 against the inner wall of the vessel 164 to enhance contact of the agents with the vessel and/or absorption of the agents into the vessel.
Referring to Figs. 27 and 28, a coil apparatus 170 having a soluble outer coating will be described. The coil apparatus 170 includes a resilient fiber core 171 that has a first linear portion and a second coil-shaped portion. The particular shape of the coil-shaped portion of the resilient fiber core 171 can be any of the shapes described above and shown in the accompanying drawings. Similarly, the particular deployment method used for the coil apparatus 170 can be any of-the methods described above and shown in the drawings. A forward feed coil shape extending away from the linear portion of the resilient fiber core 171 is shown, for example, in Fig. 27.
A soft polymer tubing 172 is slid or formed over the resilient fiber core 171, and the coil apparatus 170, including the polymer tubing 172, takes the shape of the resilient fiber core 171. An outer surface of the polymer tubing 172 is covered by a soluble coating 173 containing a therapeutic agent. The soluble coating 173 is made of a material that dissolves after the coil apparatus 170 is in place in a blood vessel or the like. Thus, the blood flow or other body fluid dissolves the soluble coating 173 and accomplishes generally the same thing as if a fluid-based drug is infused through the lumen of the polymer tubing 172. The soluble coating 173 can be made, for example, of a gelatin substance in which a therapeutic agent is suspended, or a hollow molecule material that has a therapeutic agent supplanted therein. The soluble coating 173 will leach or break off over time as the substance wets out in a body fluid, such as blood.
The soluble coating 173 placed on the outer surface of the polymer tubing 172 simplifies the introduction of therapeutic agents into the body by making it unnecessary to inject and regulate minute amounts of fluid-based agents through the lumen of the polymer tubing. Moreover, the use of a soluble coating allows a smaller size polymer tubing 172 and resilient fiber core 171 to be used, since no fluid-based agent has to be passed through the lumen of the polymer tubing 172.
For example, the resilient fiber core 171 can be in the form of a spring steel alloy having a diameter of 0.001 to 0.002 inches, and the polymer tubing 172 can have an inside diameter of 0.002 to 0.003 inches and an outside diameter of 0.003 to 0.005 inches. The soluble coating 173 covering the outer surface of the polymer tubing 172 has, for example, a thickness of approximately 0.001 inches, thereby making the overall outside diameter of the coil apparatus 0.005 to 0.007 inches. These dimensions are given by way of example only.
As explained above. the polymer tubing 172 shown in Figs. 27 and 28 need not have a lumen extending over its length for delivering fluid-based agents through the coil apparatus. Rather, the soluble coating 173 provides the means for delivering therapeutic agents as it dissolves in body fluids.
A coil apparatus I 80 according to an alternative arrangement is shown in Fig.
29. The coil apparatus 180 has a soluble coating applied over a first portion 181 of the coiled portion of the polymer tubing, while a second portion 182 of the coiled portion has openings, pores, braids, or the like for releasing fluid-based agents from a lumen of the polymer tubing. This alternative arrangement provides a means for delivering a plurality of therapeutic or diagnostic agents into a vessel, wherein part of the agents are fluid-based and part of the agents are integrated into the soluble coating.
This arrangement might be particularly useful, for example, for introducing two or more agents designed to react with each other W ithin the vessel in which the coil is disposed, rather than outside the vessel. A multiple lumen tubing, as described above, could also be used with this arrangement.
The disclosed embodiments of the present invention provide an infusion coil or coated coil apparatus that can be wrapped into a much smaller coil without permanently deforming the coil so that it will spring back to its original configuration.
The limiting factor of how small a coil can be wound is the thickness of the element to be coiled. For instance, a 0.25" diameter metallic steel heat-tempered spring alloy wire must be wound around a very large radius (several feet) to keep from permanently deforming, while a very thin diameter (e.g., 0.001 ") spring alloy wire can be wound around a very small radius (0.010") without being permanently set.
Use of "dead" soft polymer tube will follow the coil without hindering recovery of the coil to its original size during deployment. The preferred Shore D
hardness of the polymer selected for the polymer tube is approximately 40, whereby any permanent set in the polymer itself due to coiling will not hinder the coil's recovery.
Use of holes, pores, or a soluble coating around the entire periphery of the coil prevent thrombus from forming and allows for ease of manufacturing. The size of the resilient fiber core can be tailored to make the springiness of the coil variable so that the device produces a very small force on the vessel wall while still maintaining enough force to recover its coil shape during deployment.
The polymer tube can be tailored to reduce the pressure exerted by the coil on the artery wall. The configurarion of the embodiments of the present invention allow for positive and accurate deployment of the coil through existing devices and prevents the coil from dragging through the vessel during deployment. The deployment method permits positive and accurate deployment of the coil through existing devices.
As used in this application, the terms "diagnostic," "therapeutic" and "fluid-based" agents encompass any diagnostic compound, such as dyes for markers, as well as any therapeutic compound that has a desired pharmacologic effect in a particular subject. For example, the therapeutic agent can be an anticoagulant, such as D-Phe-Pro-Arg chlorometh,yl ketone, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, antithrombin antibodies, antiplatelet receptor antibodies, aspirin, protagladin inhibitors, platelet inhibitors, or tick antiplatelet peptide. The therapeutic agent could also be a promoter of vascular cell growth, such as a growth factor promotor, growth factor receptor agonist, transcriptional activator, translational promoter, or endothelia cells.
Alternatively, the therapeutic agent can be an inhibitor of vascular cell growth, such as a growth factor inhibitor, growth factor receptor antagonist, transcriptional repressor, translational repressor, antisense DNA, antisense RNA, replication inhibitor, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, and bifunctional molecules consisting of an antibody and a cytotoxin. In addition, the therapeutic agent could be a cholesterol-lowering agent, a vasodilating agent, and agents that interfere with endogenous vasoactive mechanisms.
While the present invention has been disclosed primarily in connection with treating coronary artery disease, the invention may also be used for treatment of various other body organs, including the biliary ducts, or the genital-uretal organs.
The term vessel, as used in this application, encompasses any duct, canal, or other tube that contains or conveys a body fluid.
It will be appreciated that the present invention is not limited to the exact construction or method steps that have been described above and illustrated in the accompanying drawings, and that various modifications and changes can be made without departing from the scope of the invention. It is intended that the scope of the invention only be limited by the appended claims.

Claims (26)

WE CLAIM:

1. A coil apparatus for delivering diagnostic and therapeutic agents intravascularly, comprising:
a resilient fiber core having a linear portion and a coiled portion; and a polymer tubing encasing the resilient fiber core and adapting to the shape of the resilient fiber core, said polymer tubing comprising a first portion encasing the linear portion of the resilient fiber core and a second portion encasing the coiled portion of the resilient fiber core.

2. The coil apparatus according to claim 1, wherein said polymer tubing is constructed from a braided, stitched, or other porous material, and said first portion of the polymer tubing is consolidated, coated, or impregnated so as to be non-porous, while said second portion of the polymer tubing remains porous for releasing fluid-based agents from said coil apparatus.

3. The coil apparatus according to claim 1, wherein said coiled portion of the resilient fiber core is spiral-shaped in plan view.

4. The coil apparatus according to claim 1, wherein said coiled portion of the resilient fiber core has a helical shape tapering from a relatively large proximal end to a relatively small distal end.

5. The coil apparatus according to claim 1, wherein said coiled portion of the resilient fiber core has a helical shape tapering from a relatively small proximal end to a relatively large distal end.

6. The coil apparatus according to claim 1, wherein said polymer tubing comprises at least two lumens extending along a length of said polymer tubing, said resilient fiber core extending through one of said lumens.

-30-~

7. The coil apparatus according to claim 6, wherein said polymer tubing is formed of a very soft material selected from the group consisting of nylon, urethane, PE and TFE polymer materials so as to minimize resistance to the coiled portion of the resilient fiber core and prevent damage to a vessel during use.

8. The coil apparatus according to claim 6, wherein said polymer tubing is formed of a polymer having a Shore D hardness of approximately 40.

9. The coil apparatus according to claim 6, wherein said polymer tubing is constructed of a polymer compounded with a radio opacifier at a loading high enough to make the polymer radiopaque.

10. The coil apparatus according to claim 1, further comprising an inner sheath secured to an inner diameter of said second portion of said polymer tubing, said inner sheath having a passage extending therethrough to permit fluids to continue flowing through a vessel in which the coil apparatus is deployed.

11. The coil apparatus according to claim 1, wherein at least a portion of an outer surface of said polymer tubing is covered by a soluble coating containing a therapeutic agent.

12. The coil apparatus according to claim 11, wherein said resilient fiber core has a diameter of 0.001 to 0.002 inches.

13. The coil apparatus according to claim 12, wherein said polymer tubing has an outside diameter of 0.003 to 0.005 inches and an inside diameter of 0.002 to 0.003 inches.

14. The coil apparatus according to claim 1, wherein a first portion of said polymer tubing has an outer surface covered by a soluble coating containing a therapeutic agent, and a second portion of said polymer tubing has a releasing means for releasing fluid-based agents from a lumen of the polymer tubing.

15. In combination, a coil apparatus for delivering diagnostic and therapeutic agents intravascularly and an apparatus for deploying the coil apparatus at a desired location in a vessel, said coil apparatus comprising:
a resilient fiber core having a linear portion and a coiled portion; and a polymer tubing encasing the resilient fiber core and adapting to the shape of the resilient fiber core, said polymer tubing comprising a first portion encasing the linear portion of the resilient fiber core and a second portion encasing the coiled portion of the resilient fiber core.

16. The combination according to claim 15. wherein said polymer tubing is constructed from a braided, stitched, or other porous material, and said first portion of the polymer tubing is consolidated, coated, or impregnated so as to be non-porous, while said second portion of the polymer tubing remains porous for releasing fluid-based agents from said coil apparatus.

17. The combination according to claim 15, wherein said polymer tubing comprises at least two lumens extending along a length of said polymer tubing, said resilient fiber core extending through one of said lumens.

18. The combination according to claim 15, further comprising an inner sheath secured to an inner diameter of said second portion of said polymer tubing, said inner sheath having a passage extending therethrough to permit fluids to continue flowing through a vessel in which the coil apparatus is deployed.

19. The combination according to claim 15, wherein at least a portion of an outer surface of said polymer tubing is covered by a soluble coating containing a therapeutic agent.

20. The combination according to claim 15, wherein a first portion of said polymer tubing has an outer surface covered by a soluble coating containing a therapeutic agent, and a second portion of said polymer tubing has a releasing means for releasing fluid-based agents from a lumen of the polymer tubing.

21. A method for delivering diagnostic and therapeutic agents into a vessel, comprising the steps of:
providing a coil apparatus having a resilient fiber core encased by a soft polymer tubing;
loading said coil apparatus into a delivery sheath, said delivery sheath having .
an internal diameter which is smaller than a preset diameter of a coiled portion of said resilient fiber core;
inserting said delivery sheath and said coil apparatus into a vessel; and pushing said coil apparatus out of said delivery sheath whereby said resilient fiber core causes said coil apparatus to increase in diameter and lodge in the vessel.

22. The method according to claim 21, further comprising the step of preparing the soft polymer tubing from a braided, stitched, or other porous material by consolidating, coating, or impregnating a first portion of the polymer tubing so as to make said first portion non-porous, while a second portion of the polymer tubing remains porous for releasing fluid-based agents from the coil apparatus.

23. The method according to claim 21, further comprising the step of providing at least two lumens through said polymer tubing for delivering fluid-based agents through the coil apparatus.

24. The method according to claim 21, further comprising the step of providing an inner sheath secured to an inner diameter of a portion of the polymer tubing, said inner sheath having a passage extending therethrough to permit fluids to continue flowing through a vessel in which the coil apparatus is deployed.

25. The method according to claim 21, further comprising the step of covering at least a portion of an outer surface of said polymer tubing with a soluble coating containing a therapeutic agent.

26. The method according to claim 21, further comprising the steps of covering a first portion of said polymer tubing with a soluble coating containing a therapeutic agent, and providing a releasing means in a second portion of said polymer tubing for releasing fluid-based agents from a lumen of the polymer tubing.